Sofwave (SOFW) AI Stock Analysis

• Market Cap: 943.38M
• Dividend Yield: N/A
• Average Volume (3M): 27.28K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.44
• Revenue Growth: 22.30%
• EPS Growth: 59.78%
• Country: IL
• Employees: 126
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 15.40
• Shares Outstanding: 35,572,556
• 10 Day Avg. Volume: 26,837
• 30 Day Avg. Volume: 27,278
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: 2,599.00
• Price Target Upside: -2.00% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 46 Neutral
• Price Target: 2,599.00 ▼(-2.00% Downside)

Sofwave's overall stock score is primarily impacted by its financial performance, which shows growth but lacks profitability and cash flow stability. Technical analysis indicates a neutral to bearish trend, while valuation metrics are unattractive due to negative earnings and lack of dividends.

Sofwave Business Overview & Revenue Model

Company Description

Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.

How the Company Makes Money

Sofwave generates revenue primarily through the sale and distribution of its medical devices and related consumables to dermatologists, plastic surgeons, and aesthetic practitioners. The company also offers training and support services to ensure the effective use of its technology, which can contribute to additional revenue streams. Furthermore, Sofwave may engage in partnerships or collaborations with clinics and medical facilities to expand its market reach and increase device adoption. The company's earnings are influenced by the demand for non-invasive aesthetic treatments, technological advancements, and its ability to maintain strong relationships with its distribution network.

Sofwave Financial Statement Overview

Summary

Sofwave shows positive revenue growth and a strong gross profit margin, but struggles with profitability and cash flow stability. The low debt profile is a positive indicator, but negative net profit margins and declining free cash flow growth are concerning.

Income Statement

Sofwave has shown a positive revenue growth rate of 10.05% in the TTM, indicating a growing market presence. However, the company is struggling with profitability, as evidenced by negative net profit and EBIT margins. The gross profit margin remains strong at 76.25%, suggesting efficient production processes, but the overall profitability is hindered by high operating expenses.

Balance Sheet

The balance sheet reflects a stable financial position with a low debt-to-equity ratio of 0.06, indicating low leverage and reduced financial risk. However, the return on equity is negative, highlighting challenges in generating returns for shareholders. The equity ratio is healthy, suggesting a solid capital structure.

Cash Flow

The cash flow statement shows a concerning decline in free cash flow growth, with a significant negative growth rate of -197.34% in the TTM. Despite this, the company maintains a positive free cash flow to net income ratio, indicating some ability to convert profits into cash. The operating cash flow to net income ratio is negative, reflecting challenges in cash generation from operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	69.49M	59.65M	50.31M	35.63M	21.84M	4.29M
Gross Profit	52.85M	45.34M	37.48M	26.33M	16.24M	2.63M
EBITDA	1.11M	-2.19M	-6.61M	-16.97M	-6.43M	-11.32M
Net Income	-1.63M	-4.55M	-8.28M	-19.53M	-6.83M	-11.69M
Balance Sheet
Total Assets	44.88M	43.03M	43.54M	46.08M	60.77M	4.82M
Cash, Cash Equivalents and Short-Term Investments	23.50M	21.62M	24.42M	32.01M	46.22M	2.64M
Total Debt	1.45M	1.40M	1.33M	1.92M	2.37M	78.00K
Total Liabilities	18.32M	18.50M	17.19M	13.74M	14.07M	3.29M
Stockholders Equity	26.55M	24.53M	26.34M	32.34M	46.70M	1.53M
Cash Flow
Free Cash Flow	2.60M	-2.67M	-6.71M	-11.14M	-2.92M	-5.07M
Operating Cash Flow	2.85M	-2.40M	-6.31M	-10.69M	-2.10M	-4.80M
Investing Cash Flow	-354.00K	254.00K	409.00K	-260.00K	-982.00K	-263.00K
Financing Cash Flow	-292.00K	-620.00K	-1.72M	-1.35M	46.64M	1.99M

Sofwave Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2652.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:SOFW, the sentiment is Positive. The current price of 2652 is above the 20-day moving average (MA) of 2643.75, below the 50-day MA of 2681.54, and above the 200-day MA of 2008.35, indicating a neutral trend. The MACD of -43.03 indicates Positive momentum. The RSI at 50.74 is Neutral, neither overbought nor oversold. The STOCH value of 45.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:SOFW.

Sofwave Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BWAY	78 Outperform	961.20M	48.30	4.69%	―	23.45%	670.44%
SOFW	46 Neutral	943.38M	―	―	―	22.30%	59.78%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%